Molecular mechanisms regulating leukocyte trafficking
调节白细胞运输的分子机制
基本信息
- 批准号:9890986
- 负责人:
- 金额:$ 18.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-11 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgentsAdrenergic ReceptorAffectAutoimmune DiseasesBioluminescenceCXCRCXCR4 ReceptorsCXCR4 geneCatecholaminesCell LineCell surfaceCellsChemotaxisComplexDataDevelopmentDiseaseEnergy TransferExploratory/Developmental GrantFamilyG-Protein-Coupled ReceptorsGTP-Binding ProteinsHealthHumanIL8RB geneImmuneImmune systemInfectionInflammationInnate Immune SystemInterleukin-8B ReceptorLeadLeukocyte TraffickingLeukocytesMalignant NeoplasmsMediatingModelingMolecularMolecular BiologyMolecular TargetMusNervous system structurePatientsPatternPeripheral Blood Mononuclear CellPeritonitisPharmacologyPlayPopulationProcessProstateProtein FamilyReceptor SignalingRecombinantsRegulationRodentRoleSeriesSignal TransductionSmooth MuscleSmooth Muscle MyocytesStressSystemTestingTransmembrane DomainVascular Smooth Musclecell motilitychemokinechemokine receptorexperimental studyfightinghuman migrationimmune functionimmunoregulationin vivoinnate immune functioninsightmembermigrationmonocytereceptorreceptor expressionreceptor functionrecruitresponsesymposiumtissue injurytreatment strategy
项目摘要
Project Summary/Abstract
The autonomous nervous system regulates innate immune functions during the stress or “fight and flight”
response through the release of endogenous catecholamines, which activate the G protein-coupled receptor
(GPCR) family of adrenergic receptors (ARs) expressed in the immune system. The roles of α1-ARs in the
regulation of innate immune functions, however, are poorly understood and the molecular mechanisms
underlying cross-talk between the neurohormonal and innate immune system remain to be determined. The
family of chemokine receptors (CRs) is essential for the regulation of leukocyte recruitment and plays important
roles in all aspects of inflammation and in numerous disease processes. Recently, we discovered that α1-ARs
form hetero-oligomeric complexes with chemokine (C-X-C motif) receptor (CXCR) 4 and with atypical chemokine
receptor (ACKR) 3, and that α1B-AR within heteromeric CXCR4:α1B-AR complexes regulates CXCR4-mediated
migration of human vascular smooth muscle cells. It is unknown whether heteromeric complexes between CRs
and α1-ARs exist in leukocytes. We observed in pilot experiments that hetero-oligomeric complexes between
α1A/B/D-AR and CXCR4 are detectable on the cell surface of THP-1 cells and in freshly isolated human peripheral
blood mononuclear cells. Furthermore, we performed preliminary intermolecular bioluminescence resonance
energy transfer (BRET) experiments and detected that α1b-AR is able to form heteromeric complexes with
multiple members of the CR family. This leads to our working hypothesis that the formation of hetero-oligomeric
complexes between α1-ARs and CRs is a common molecular mechanism through which the neurohormonal
system interacts with the innate immune system to regulate CR-mediated leukocyte trafficking in health and
disease. To test this hypothesis, we will focus on monocytes as a major cell population in the innate immune
system and on heteromers between CRs and α1B-AR to provide proof-of-concept. We propose the following
specific aims: 1. To study the distribution and function of CR:α1B-AR heteromeric complexes in human
monocytes. We will determine which CRs are able to form heteromers with α1B-AR, define the patterns of
receptor heteromerization and assess the effects of receptor heteromerization on CR signaling and function. 2.
To assess the roles of α1-ARs and of CR:α1B-AR heteromeric complexes in the regulation of monocyte
recruitment during inflammation in vivo. Here we will utilize MacBlue mice in a peritonitis model to evaluate
the roles of α1-ARs and CR:α1B-AR heteromers in the regulation of monocyte migration in inflammation. The
proposed exploratory/developmental studies will provide the scientific basis to establish receptor
heteromerization as a mechanism through which the neurohormonal system controls CR-mediated leukocyte
trafficking. These data could lead to a paradigm shift in the understanding of the regulation of leukocyte
recruitment and are expected to identify new molecular targets to modulate innate immune functions in numerous
disease processes, which has the potential to facilitate the development of new treatment strategies for patients.
项目总结/摘要
自主神经系统在压力或“战斗和逃跑”期间调节先天免疫功能
通过释放内源性儿茶酚胺来激活G蛋白偶联受体
在免疫系统中表达的肾上腺素能受体(AR)的GPCR家族。α1-ARs在肿瘤发生中的作用
然而,对先天免疫功能的调节知之甚少,
神经激素和先天免疫系统之间潜在的相互作用仍有待确定。的
趋化因子受体(CRs)家族对于白细胞募集的调节是必需的,并且起重要作用
在炎症的各个方面和许多疾病过程中发挥作用。最近,我们发现α1-AR
与趋化因子(C-X-C基序)受体(CXCR)4和非典型趋化因子形成异源寡聚复合物
CXCR 4:α1B-AR复合物中的α1B-AR调节CXCR 4介导的
人血管平滑肌细胞的迁移。目前尚不清楚CR之间的异聚复合物是否
白细胞中存在α1-AR。我们在初步实验中观察到,
α 1 A/B/D-AR和CXCR 4可在THP-1细胞的细胞表面和新鲜分离的人外周血中检测到
血单核细胞此外,我们进行了初步的分子间生物发光共振,
能量转移(BRET)实验,并检测到α1b-AR能够与
CR家族的多个成员。这导致我们的工作假设,异源寡聚体的形成
α1-AR和CRs之间的复合物是一种常见的分子机制,通过这种机制,神经激素
系统与先天免疫系统相互作用,以调节健康状况下CR介导的白细胞运输,
疾病为了验证这一假设,我们将重点放在单核细胞作为一个主要的细胞群体在先天免疫,
系统和CRs和α1B-AR之间的异聚体,以提供概念验证。我们提议下列
具体目标:1.研究CR:α1B-AR异聚体复合物在人体内的分布和功能
单核细胞我们将确定哪些CR能够与α1B-AR形成异聚体,定义
受体异聚化并评估受体异聚化对CR信号传导和功能的影响。2.
评价α1-AR和CR:α1B-AR异聚体复合物在单核细胞调节中的作用,
体内炎症过程中的募集。在这里,我们将利用MacBlue小鼠腹膜炎模型,以评估
α1-AR和CR:α1B-AR异聚体在炎症单核细胞迁移调节中的作用。的
拟议的探索性/开发性研究将为建立受体提供科学依据。
异聚化作为神经激素系统控制CR介导的白细胞的机制
贩卖人口这些数据可能会导致对白细胞调节的理解发生范式转变,
招募,并预计将确定新的分子靶点,以调节先天免疫功能,在许多
疾病过程,这有可能促进为患者开发新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthias Majetschak其他文献
Matthias Majetschak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthias Majetschak', 18)}}的其他基金
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10091901 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10641113 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10646227 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10377625 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10439841 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10254299 - 财政年份:2020
- 资助金额:
$ 18.69万 - 项目类别:
Chemokine control of cardiovascular function during hemorrhagic shock
失血性休克期间趋化因子对心血管功能的控制
- 批准号:
8693520 - 财政年份:2014
- 资助金额:
$ 18.69万 - 项目类别:
Chemokine control of cardiovascular function during hemorrhagic shock
失血性休克期间趋化因子对心血管功能的控制
- 批准号:
8897415 - 财政年份:2014
- 资助金额:
$ 18.69万 - 项目类别:
Chemokine control of cardiovascular function during hemorrhagic shock
失血性休克期间趋化因子对心血管功能的控制
- 批准号:
9111960 - 财政年份:2014
- 资助金额:
$ 18.69万 - 项目类别:
Chemokine control of cardiovascular function during hemorrhagic shock
失血性休克期间趋化因子对心血管功能的控制
- 批准号:
9701546 - 财政年份:2014
- 资助金额:
$ 18.69万 - 项目类别:
相似海外基金
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 18.69万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
- 批准号:
RGPIN-2019-04706 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
- 批准号:
22K07118 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)